Zimmer Biomet Inc. (ZBH) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

Zimmer Biomet Inc.

NYSE: ZBH · Real-Time Price · USD
104.24
1.94 (1.90%)
At close: Sep 11, 2025, 3:59 PM
104.20
-0.04%
Pre-market: Sep 12, 2025, 05:39 AM EDT

Zimmer Biomet Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
7.68B 7.39B 6.94B 6.83B
Cost of Revenue
2.19B 2.08B 2.02B 1.96B
Gross Profit
5.49B 5.31B 4.92B 4.87B
Operating Income
1.29B 1.28B 696.3M 860.3M
Interest Income
n/a n/a n/a n/a
Pretax Income
1.04B 1.07B 403.5M 499M
Net Income
903.8M 1.02B 231.4M 401.6M
Selling & General & Admin
2.93B 2.84B 2.76B 2.84B
Research & Development
437.4M 458.7M 406M 435.8M
Other Expenses
834.5M 735.1M 1.06B 727.4M
Operating Expenses
4.2B 4.03B 4.22B 4.01B
Interest Expense
218M 201.2M 164.8M 208.4M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
6.39B 6.12B 6.24B 5.97B
Income Tax Expense
131.4M 42.2M 112.3M 53.5M
Shares Outstanding (Basic)
203.1M 208.7M 209.6M 208.6M
Shares Outstanding (Diluted)
203.9M 209.7M 210.3M 210.4M
EPS (Basic)
4.45 4.91 1.39 1.93
EPS (Diluted)
4.43 4.88 1.38 1.91
EBITDA
2.25B 2.22B 1.49B 1.65B
EBIT
1.25B 1.27B 568.3M 707.4M
Depreciation & Amortization
996.3M 951.7M 926.4M 937.7M